Skip to content
Aminoscope
← Research
GLP-1

How to get Ozempic in 2026: the honest pathway

Ozempic is a diabetes drug, so how you get it depends on why you want it. For diabetes it's on-label and often covered; for weight loss it's off-label and usually points to Wegovy. Here's the real route, and the real cost.

Priya Anand7 min read
How to get Ozempic depends on why — diabetes is on-label; weight loss is off-labelOzempicFor diabetes — on-labeloften covered by insuranceFor weight loss — off-labelusually points to WegovyTHE ROUTE DEPENDS ON WHY YOU WANT IT

To get Ozempic you need a prescription, and it is FDA-approved only for people with type 2 diabetes, so insurance usually covers it for diabetes and rarely for weight loss. As of October 2026, covered commercial patients can pay $25; uninsured self-pay is $349 a month ($199 intro, $499 for 2 mg).

“How do I get Ozempic?” has a different answer depending on a single question: why do you want it? Ozempic is a diabetes drug, and that one fact drives everything — who can prescribe it, whether insurance pays, and whether you should actually be asking about a different drug entirely. Here’s the honest pathway.

First, the thing most guides skip: Ozempic is a diabetes drug

Ozempic (semaglutide) is FDA-approved to improve blood sugar in adults with type-2 diabetes, to reduce cardiovascular events in diabetics with heart disease, and (since 2025) to slow kidney-disease progression in diabetics with chronic kidney disease.[1] It is not FDA-approved for weight loss. The semaglutide drug that is approved for weight loss is Wegovy — same molecule, different brand and indication. So the first fork in the road is your reason for wanting it.

Ozempic is a diabetes drug; the route to it depends entirely on why you want it.
Your reasonThe realistic route
Type-2 diabetesOn-label Ozempic — doctor prescribes, insurance often covers
Weight loss, no diabetesOff-label and usually uncovered — consider Wegovy instead
Heart/kidney risk + diabetesOn-label Ozempic, with its CV/kidney indications
Ozempic is a diabetes drug; the route to it depends entirely on why you want it. FDA-approved indications, Ozempic prescribing information (2025)

How do you get Ozempic if you have type 2 diabetes?

This is the straightforward path. A primary-care doctor or endocrinologist diagnoses type-2 diabetes (typically via A1c or fasting glucose) and can prescribe Ozempic on-label. Because it’s being used for its approved purpose, commercial plans and Medicare Part D commonly cover it — subject to formulary tier, prior authorization, and sometimes step therapy (trying a cheaper drug like metformin first).[2] If your plan covers it, Novo’s savings card can bring the copay to as little as $25/month (capped at $100/month savings, for up to 48 months) — for commercially insured patients only.[2]

Can you get Ozempic for weight loss?

A doctor may legally prescribe Ozempic off-label for weight loss at their discretion, and some in-person and telehealth clinicians do. But two things make this the harder road: insurance generally will not cover Ozempic for weight loss, and the manufacturer savings card is tied to the approved diabetes indication, so it won’t rescue an off-label prescription.[2]That’s exactly why the sensible move for most people without diabetes is the on-label sibling: Wegovy (or, for tirzepatide, Zepbound). See our Ozempic vs Wegovy comparison for why they’re the same drug pointed at different goals.

How much does Ozempic cost?

Ozempic’s list price is roughly $1,000 a month — a number Novo has said will fall to $675 on January 1, 2027, a cut of about 35%.[5] Almost no one with a working route pays the sticker, though. For uninsured patients, Novo’s self-pay price is $199/month for the first two months on the 0.25 mg and 0.5 mg pens (for new patients, through December 31, 2026), then $349/month for 0.25 mg, 0.5 mg or 1 mg and $499/month for 2 mg (October 2026).[2] The full breakdown lives in our semaglutide cost guide and GLP-1 cost and insurance explainer, and you can model your own scenario in the GLP-1 cost estimator.

What about compounded Ozempic?

During the 2023–24 shortage, cheap compounded semaglutide was everywhere. That door has largely closed. Semaglutide came off the FDA shortage list in early 2025, ending the mass compounding exemption. In February 2026 the FDA announced it intends to restrict GLP-1 ingredients meant for mass-marketed, non-approved compounded copies, and on April 30, 2026 it proposed excluding semaglutide from the bulk substances outsourcing facilities may compound; the extended comment period closed July 30, 2026, and no final decision had been announced as of October 2026.[3] Narrow, patient-specific compounding can still be legal with a documented medical need, but a cheap “compounded Ozempic” subscription is no longer a reliable or clearly-legal route — read our compounded vs branded guide before going that way.

The honest bottom line

If you have type-2 diabetes, getting Ozempic is straightforward and often covered — see a doctor, confirm the diagnosis, and use the savings card if you’re commercially insured.[2] If you want it purely for weight loss, Ozempic is off-label and usually uncovered, and the right question is really about Wegovy (or Zepbound). Whichever applies, compare the legitimate telehealth routes in our best GLP-1 providers roundup, and start from the evidence in our semaglutide evidence guide.

Reviewed against primary sources by the Aminoscope desk

Frequently asked

Can you get Ozempic for weight loss?
A doctor may legally prescribe Ozempic off-label for weight loss, but insurance generally will not cover it for that use and the manufacturer savings card is tied to the diabetes indication, so for most people without diabetes the sensible on-label route is Wegovy — the same molecule approved for weight loss.
Who can prescribe Ozempic?
If you have type-2 diabetes, a primary-care doctor or endocrinologist can diagnose it (typically via A1c or fasting glucose) and prescribe Ozempic on-label, which is when commercial plans and Medicare Part D commonly cover it — subject to formulary tier, prior authorization, and sometimes step therapy.
How much does Ozempic cost?
Ozempic's list price is roughly $1,000 a month (falling to $675 on January 1, 2027), though almost no one with a working route pays the sticker. With covered commercial insurance the savings card can drop the copay to as little as $25/month; uninsured, Novo's self-pay price is $199/month for the first two months, then $349 (0.25–1 mg) or $499 (2 mg), as of October 2026.
Is Ozempic approved for weight loss?
No. Ozempic (semaglutide) is FDA-approved to improve blood sugar in adults with type-2 diabetes, to reduce cardiovascular events in diabetics with heart disease, and to slow kidney-disease progression in diabetics with chronic kidney disease; it is not FDA-approved for weight loss, whereas Wegovy — the same molecule — is.
Can I still buy compounded Ozempic?
That door has largely closed: semaglutide came off the FDA shortage list in early 2025, ending the mass compounding exemption, and on April 30, 2026 the FDA proposed excluding it from the bulk substances outsourcing facilities may compound; the comment period closed July 30, 2026, with no final decision announced as of October 2026. Narrow, patient-specific compounding can still be legal with a documented medical need, but a cheap "compounded Ozempic" subscription is no longer a reliable or clearly-legal route.

Sources

  1. [1] U.S. Food & Drug Administration; Novo Nordisk. (2025). Ozempic (semaglutide) injection — FDA-approved indications (type-2 diabetes; cardiovascular and chronic-kidney-disease risk reduction). Ozempic Prescribing Information. Source
  2. [2] Novo Nordisk. (2026). Save on Ozempic — savings card (commercial), self-pay offer, government-insurance exclusion, and list-price information. Novo Nordisk, Save on Ozempic (accessed October 2026). Source
  3. [3] U.S. Food & Drug Administration. (2026). FDA proposes to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulk drug substances list (April 30, 2026; comment period extended to July 30, 2026). FDA press announcement. Source
  4. [4] Centers for Medicare & Medicaid Services. (2026). Medicare GLP-1 Bridge: Information for Prescribers (eligibility criteria and covered drugs), CMS Product No. 12235. CMS (June 2026). Source
  5. [5] Novo Nordisk. (2026). Novo Nordisk announces significant reduction in US list price for Wegovy, Ozempic, and Rybelsus (semaglutide medicines) (February 24, 2026). Novo Nordisk press release. Source

Where to get it

Ozempic alternatives, compared

Cheaper and easier ways to get a GLP-1 than branded Ozempic — compounded semaglutide, tirzepatide, and who offers them.

Compare providers →

Related tool

GLP-1 weight-loss comparison

See semaglutide, tirzepatide, retatrutide and the pipeline ranked by mean trial weight loss — every figure traced to its source.

More in GLP-1